Rituximab in Auto-Immune Hemolytic Anemia

NCT01181154 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Warm Autoimmune Hemolytic Anemia

Interventions

DRUG: rituximab (Mabthera®)
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]